NCT07599371: A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory Glioma
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 29 planned
- Started
- 10 Oct 2024
- Primary completion
- 10 Oct 2027
- Arms
- ivoximab combined with temozolomide
- Results
- None posted
- 10 Oct 2024: Trial started
- 20 May 2026: Trial registered